Emtricitabine for adults with lamivudine-resistant chronic hepatitis B virus infection

To evaluate the benefits and harms of emtricitabine versus no intervention, placebo, and non-emtricitabine interventions in adults with lamivudine-resistant, chronic hepatitis B virus infection.

This is a protocol.

Share/Save